Patents by Inventor Juan E. Diaz

Juan E. Diaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AGAINST CDCP1 FOR THE TREATMENT AND DETECTION OF CANCER
    Publication number: 20230265206
    Abstract: The disclosure is related to antibodies and antibody fragments that specifically bind the CUB domain-containing protein 1 (CDCP1) and their methods and uses in treating and detecting cancers.
    Type: Application
    Filed: March 10, 2023
    Publication date: August 24, 2023
    Applicant: The Regents of the University of California
    Inventors: James A. WELLS, Alexander J. MARTINKO, Juan E. DIAZ, Michael J. HORNSBY
  • Antibodies against CDCP1 for the treatment and detection of cancer
    Patent number: 11603412
    Abstract: The disclosure is related to antibodies and antibody fragments that specifically bind the CUB domain-containing protein 1 (CDCP1) and their methods and uses in treating and detecting cancers.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: March 14, 2023
    Assignee: The Regents of the University of California
    Inventors: James A. Wells, Alexander J. Martinko, Juan E. Diaz, Michael J. Hornsby
  • ANTIBODIES AGAINST CDCP1 FOR THE TREATMENT AND DETECTION OF CANCER
    Publication number: 20210179729
    Abstract: The disclosure is related to antibodies and antibody fragments that specifically bind the CUB domain-containing protein 1 (CDCP1) and their methods and uses in treating and detecting cancers.
    Type: Application
    Filed: October 25, 2018
    Publication date: June 17, 2021
    Applicant: The Regents of the University of California
    Inventors: James A. WELLS, Alexander J. MARTINKO, Juan E. DIAZ, Michael J. HORNSBY
  • Compositions, devices, and methods related to prostate-specific membrane antigen
    Patent number: 8986655
    Abstract: PSMA ligands, compositions, and methods therefore are disclosed where the ligand is a peptide having the sequence X1X2CVEVX3QNSCX4X5 where X1-X5 are independently a natural or non-natural amino acid or a peptide having the sequence CALCEFLG [SEQ ID NO: 1]. Especially preferred aspects include diagnostic reagents for detection and/or quantification of PSMA in a sample, therapeutic reagents, and diagnostic imaging reagents.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: March 24, 2015
    Assignee: The Regents of the University of California
    Inventors: Gregory A. Weiss, Jessica Arter, Juan E. Diaz
  • Compositions, Devices, and Methods related to Prostate-Specific Membrane Antigen
    Publication number: 20120183478
    Abstract: PSMA ligands, compositions, and methods therefore are disclosed where the ligand is a peptide having the sequence X1X2CVEVX3QNSCX4X5 where X1-X5 are independently a natural or non-natural amino acid or a peptide having the sequence CALCEFLG [SEQ ID NO: 1]. Especially preferred aspects include diagnostic reagents for detection and/or quantification of PSMA in a sample, therapeutic reagents, and diagnostic imaging reagents.
    Type: Application
    Filed: May 19, 2010
    Publication date: July 19, 2012
    Inventors: Gregory A. Weiss, Jessica Arter, Juan E. Diaz